Injective and Pineapple Expand On-chain Strategy Amidst INJ Price Momentum
Injective's collaboration with Pineapple Financial advances with Pentiv, as analysts eye potential price breakout.
Injective's collaboration with Pineapple Financial advances with Pentiv, as analysts eye potential price breakout. Injective (INJ) is trading at ₹818 ($8.60), up 1.1% since this brief published. This is an original Token Times brief based on reporting by TronWeekly, with live market data added, as of Sun, 18 Oct 2026 00:15:01 UTC.
The expansion of on-chain mortgage records and treasury strategy could strengthen Injective's DeFi ecosystem and potentially influence its token's market performance.
- Injective and Pineapple advance with Pentiv, building on $1B+ in on-chain mortgages.
- INJ price shows +12.45% 7-day growth, currently trading at $8.51.
- Analysts predict potential breakout with $35 as a target if resistance breaks.
Injective is advancing its collaboration with Pineapple Financial through the Pentiv development phase, which focuses on expanding on-chain mortgage records and a $100 million INJ treasury strategy. This development follows the successful onboarding of over $1 billion in mortgage records onto the blockchain.
The announcement comes as the INJ token shows significant price momentum, with a 7-day increase of 12.45% and a current trading price of $8.51. Despite this, the token experienced a slight 1.83% dip in the past 24 hours.
Analyst Prof. Clifton has highlighted a potential breakout from a descending broadening wedge, suggesting that if the current resistance is broken, the price could target $35. This prediction adds a layer of optimism to the recent developments.
The broader crypto market remains relatively flat with a total market cap of $2.79 trillion, while 
Bitcoin has seen a minor 0.54% decline in the past 24 hours. The overall market sentiment, as indicated by the Fear & Greed index, stands at 55, indicating a state of 'Greed'.
The expansion of on-chain mortgage records and the strategic treasury management could enhance Injective's position in the DeFi space. Observers will be watching to see if the INJ token can maintain its momentum and if the predicted breakout materializes.
Since this brief published about 2 hours ago, Injective (INJ) has moved from ₹809.40$8.51 to ₹817.96$8.60 — +1.06%.
The chart plots INJ's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from Token Times's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 INJ ≈ ₹897.63 (about $8.60), down 1.1% over 24 hours. The rupee itself trades about 9.7% above the official rate on the P2P market, so a Indian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.
Figures and sectors in this story, checked live against on-chain aggregators · October 17, 2026.
Token Times reads these figures directly from on-chain aggregators (DeFiLlama, mempool.space) at build time — independent of what any outlet reported. Sector totals aggregate every protocol DeFiLlama tracks in that category. Values are live and will change.
Injective and Pineapple Expand On-chain Strategy Amidst INJ — questions & answers
What is the significance of the Pentiv development phase?
Pentiv marks the next step in Injective and Pineapple's collaboration, focusing on expanding on-chain mortgage records and a $100 million INJ treasury strategy.
What is the potential price target for INJ according to analysts?
Analysts predict a potential breakout with a target of $35 if the current resistance is overcome.
How much is 1 Injective worth in rupee today?
About ₹897.63 at the live peer-to-peer (P2P) USDT rate, which is what Indians typically trade at — equivalent to roughly $8.60. The rupee price moves with both INJ's US-dollar price and the USDT/INR rate; use our Injective in rupee page for any amount.
Has Injective's price moved since this brief was published?
INJ is up 1.06% since this brief first published — trading at ₹818 ($8.60) now versus ₹809 ($8.51) at publication. Token Times re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original Token Times brief that synthesises reporting from TronWeekly. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original Token Times brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.